Thursday, October 21, 2021

BLK stock: BlackRock, Inc. | Plan to purchase BLK first share

 BlackRock, Inc. is an American multinational investment management corporation based in New York City. Founded in 1988, initially as a risk management and fixed income institutional asset manager, BlackRock is the world's largest asset manager, with just over $9 trillion in assets under management as of July 2021.[2][7] BlackRock operates globally with 70 offices in 30 countries and clients in 100 countries.[8]

History[edit]

1988–1997[edit]

BlackRock was founded in 1988 by Larry Fink, Robert S. Kapito, Susan Wagner, Barbara Novick, Ben Golub, Hugh Frater, Ralph Schlosstein, and Keith Anderson[9] to provide institutional clients with asset management services from a risk management perspective.[10] Fink, Kapito, Golub and Novick had worked together at First Boston, where Fink and his team were pioneers in the mortgage-backed securities market in the United States.[11] During Fink's tenure, he had lost $100 million as head of First Boston. That experience was the motivation to develop what he and the others considered to be excellent risk management and fiduciary practices. Initially, Fink sought funding (for initial operating capital) from Pete Peterson of The Blackstone Group who believed in Fink's vision of a firm devoted to risk management. Peterson called it Blackstone Financial Management.[12] In exchange for a 50 percent stake in the bond business, initially Blackstone gave Fink and his team a $5 million credit line. Within months, the business had turned profitable, and by 1989 the group's assets had quadrupled to $2.7 billion. The percent of the stake owned by Blackstone also fell to 40%, compared to Fink's staff.[12]

By 1992, Blackstone had a stake equating to about 35% of the company, and Schwarzman and Fink were considering selling shares to the public.[13] The firm adopted the name BlackRock in 1992, and by the end of that year, BlackRock was managing $17 billion in assets. At the end of 1994, BlackRock was managing $53 billion.[14] In 1994, Blackstone Group's Stephen A. Schwarzman and Fink had an internal dispute over methods of compensation[13] and over equity.[citation needed] Fink wanted to share equity with new hires, to lure talent from banks, unlike Schwarzman, who did not want to further lower Blackstone's stake.[13] They agreed to part ways, so the BlackRock partners (Sue Wagner) orchestrated a deal to sell part of the company.[citation needed] In June 1994, Blackstone sold a mortgage-securities unit with $23 billion in assets to PNC Bank Corp. for $240 million.[15] The unit had traded mortgages and other fixed-income assets, and during the sales process the unit changed its name from Blackstone Financial Management to BlackRock Financial Management.[13] Schwarzman remained with Blackstone, while Fink went on to become chairman and CEO of BlackRock Inc.[13] In 1998, PNC's equity, liquidity, and mutual fund activities were merged into BlackRock.[citation needed]

1999–2009[edit]

BlackRock went public in 1999 at $14 a share[16] on the New York Stock Exchange.[14] By the end of 1999, BlackRock was managing $165 billion in assets.[14] BlackRock grew both organically and by acquisition. In August 2004, BlackRock made its first major acquisition, buying State Street Research & Management's holding company SSRM Holdings, Inc. from MetLife for $325 million in cash and $50 million in stock. The acquisition raised BlackRock's assets under management from $314 billion to $325 billion.[17] The deal included the mutual-fund business State Street Research & Management in 2005.[15] BlackRock merged with Merrill Lynch Investment Managers (MLIM) in 2006,[14][18] halving PNC's ownership and giving Merrill Lynch a 49.5% stake in the company.[19] In October 2007, BlackRock acquired the fund-of-funds business of Quellos Capital Management.[20][21]

The U.S. government contracted with BlackRock to help resolve the fallout of the financial meltdown of 2008. According to Vanity Fair, the financial establishment in Washington and on Wall Street believed BlackRock was the best choice for the job.[22] The Federal Reserve allowed BlackRock to superintend the $130 billion-debt settlement of Bear Stearns and American International Group.[23]

In 2009, BlackRock first became the No. 1 asset manager worldwide.[15] In April 2009, BlackRock acquired R3 Capital Management, LLC and took control of the $1.5 billion fund.[24] On 12 June 2009, Barclays sold its Global Investors unit (BGI), which included its exchange traded fund business, iShares, to BlackRock for US$13.5 billion. Through the deal, Barclays attained a near-20% stake in BlackRock.[25]

2010–2019[edit]

In 2010, Ralph Schlosstein, the CEO of Evercore Partners and a BlackRock founder, called BlackRock "the most influential financial institution in the world."[26] On 1 April 2011, due to Sanofi's acquisition of Genzyme, BlackRock replaced it on the S&P 500 index.[27]

In 2013, Fortune listed BlackRock on its annual list of the world's 50 Most Admired Companies.[15] In 2014, The Economist said that BlackRock's $4 trillion under management made it the "world's biggest asset manager", and it was larger than the world's largest bank, the Industrial and Commercial Bank of China with $3 trillion.[28] In May of the same year, BlackRock invested in Snapdeal.[29]

In December 2014 a BlackRock managing director in London was banned by the British Financial Conduct Authority for failing the "fit and proper" test, because he paid £43,000 to avoid prosecution for dodging train fares. BlackRock said, "Jonathan Burrows left BlackRock earlier this year. What he admitted to the FCA is totally contrary to our values and principles."[30][31]

At the end of 2014, the Sovereign Wealth Fund Institute reported that 65% of Blackrock's assets under management were made up of institutional investors.[32]

By June 30, 2015, BlackRock had US$4.721 trillion of assets under management.[33] On August 26, 2015, BlackRock entered into a definitive agreement to acquire FutureAdvisor,[34] a digital wealth management provider with reported assets under management of $600 million.[35] Under the deal, FutureAdvisor would operate as a business within BlackRock Solutions (BRS).[34] BlackRock announced in November 2015 that they would wind down the BlackRock Global Ascent hedge fund after losses. The Global Ascent fund had been its only dedicated global macro fund, as BlackRock was "better known for its mutual funds and exchange traded funds." At the time, BlackRock managed $51 billion in hedge funds, with $20 billion of that in funds of hedge funds.[36]

In March 2017, the Financial Times announced that BlackRock, after a six-month review led by Mark Wiseman, had initiated a restructuring of its $8bn actively-managed fund business, resulting in the departure of seven portfolio managers and a $25m charge in Q2, replacing certain funds with quantitative investment strategies.[37] In May 2017, BlackRock increased its stake in both CRH plc and Bank of Ireland.[38] By April 2017, iShares business accounted for $1.41tn, or 26 percent, of BlackRock's total assets under management, and 37 percent of BlackRock's base fee income.[39] In April 2017, BlackRock backed the inclusion of mainland Chinese shares in MSCI's global index for the first time.[40]

Between October and December 2018, BlackRock's assets dropped by US$468bn and fell below $6tn. It was the largest decline between quarters since September 2011.[41]

As of 2019, BlackRock holds 4.81% of Deutsche Bank, making it the single largest shareholder.[42] This investment goes back to at least 2016.[43]

In May 2019, BlackRock received criticism for the environmental impact of its holdings.[44] It is counted among the top three shareholders in every oil "supermajor" except Total, and it is among the top 10 shareholders in 7 of the 10 biggest coal producers.

2020[edit]

In his 2020 annual open letter,[45] CEO Fink announced environmental sustainability as a core goal for BlackRock's future investment decisions.[46] BlackRock disclosed plans to sell US$500 million in coal investments.[47]

In March 2020, the Federal Reserve chose BlackRock to manage two corporate bond-buying programs in response to the coronavirus pandemic, the $500 billion Primary Market Corporate Credit Facility (PMCCF) and the Secondary Market Corporate Credit Facility (SMCCF), as well as purchase by the Federal Reserve System of commercial mortgage-backed securities (CMBS) guaranteed by Government National Mortgage Association, Federal National Mortgage Association, or Federal Home Loan Mortgage Corporation.[23][48][49]

In August 2020, BlackRock received approval from the China Securities Regulatory Commission to set up a mutual fund business in the country. This makes BlackRock the first global asset manager to get consent from China to start operations.[50][51]

In January 2020, PNC sold its stake in BlackRock.[52]

Finances[edit]

For the fiscal year 2017, BlackRock reported earnings of US$4.970 billion, with an annual revenue of US$12.491 billion, an increase of 12.0% over the previous fiscal cycle. BlackRock's shares traded at over $414 per share, and its market capitalization was valued at over US$61.7 billion in October 2018.[53] As of 2018, BlackRock ranked 237 on the Fortune 500 list of the largest United States corporations by revenue.[54]

Year[55]Revenue
(million USD)
Net income
(million USD)
Total assets
(million USD)
AUM[56]
(million USD)
Price per
share (USD)
Employees
20051,1912341,84862.852,151
20062,09832320,469103.755,113
20074,84599322,561128.695,952
20085,06478419,924144.075,341
20094,700875178,124136.798,629
20108,6122,063178,4593,561,000145.859,127
20119,0812,337179,8963,513,000148.2710,100
20129,3372,458200,4513,792,000158.5310,500
201310,1802,932219,8734,325,000238.5211,400
201411,0813,294239,7924,651,895289.8012,200
201511,4013,345225,2614,645,412322.6813,000
201612,2613,168220,1775,147,852334.1613,000
201713,6004,952220,2176,288,195414.6013,900
201814,1984,305159,5735,975,818492.9814,900
201914,5394,476168,6227,430,000448.2216,200
202016,2054,932176,9828,677,000558.5616,500

The non-profit American Economic Liberties Project issued a report highlighting the fact that currently "the 'Big Three' asset management firms—BlackRock, Vanguard and State Street—manage over $15 trillion in combined global assets under management, an amount equivalent to more than three-quarters of U.S. gross domestic product."[57] The Report called for structural reforms and better regulation of the financial markets.

Mergers and acquisitions

Weekly plan: Manage my daily life | Oct. 21 - Oct. 24, 2021

Oct. 21, 2021

Think about working on so many things this week, including system design, cloud solution, and all other projects. 

  1. Work on small projects: health, tooth, and relationships
  2. Work on pandemic knowledge update
  3. Running – planning to have more running activities, Sunday UBC running 10 K
  4. House cleaning – more cleaning, clothing donation
  5. Microsoft small business app – installation issues
  6. Mobile phone plan
  7. Car maintenance
  8. Work on frozen shoulder recovery
  9. Call my brother and ask my nephew and his family. As about his graduate study, make some plans,  what to work on
  10. Work on other things – plan carefully 

Earnings date: Oct. 21, 2021 | Day one to study finviz.com -> Earnings Date product feature

Oct. 21, 2021

Introduction

I like to be a better investor, so that I decide to go over earnings date on finviz.com, so that I can learn more businesses. 

Steps to go over on finviz.com | My purchase 

Finviz.com -> screener -> Description -> Earnings date

I purchased 100 shares of ABB stock. 



ABB stock: 5.5% loss earnings date Oct 21, 2021 | 100 shares purchase | 瑞典通用电气布朗-博韦里(Asea Brown Boveri,一般使用其简称ABB)

Oct. 21, 2021

I like to go over finviz.com earning date: Oct. 21, 2021, and then spend time to study all those biggest companies day by day.  

瑞典通用电气布朗-博韦里(Asea Brown Boveri,一般使用其简称ABB)是一家总部在瑞士苏黎世的瑞士-瑞典的跨国公司,经营范围主要以机器人、电机、能源、自动化等领域。2018年,该公司在财富世界500强中排名第314位,已连续位列该榜单23年[4]。

ABB是全球最大的工程公司之一,也是世界上最大的企业集团之一。ABB在全球100多国设有分公司或办事处,2013年11月大约15万名员工,[3]并报告2011年的全球营收为400亿。[1]

总公司设于瑞士的苏黎世。ABB的股票自从1999年分别在苏黎世的瑞士证券交易所、斯德哥尔摩的斯德哥尔摩证券交易所上市,及从2001年在美国纽约证券交易所上市买卖,从2005年9月在伦敦证券交易所和从2005年11月在法兰克福证券交易所上市。[5]

ABB的营收有一半以上是来自欧洲市场,五分之一来自亚洲、中东和非洲,四分之一来自北美和南美洲市场。

ABB有两个核心事业部,电力技术事业部和自动化技术事业部,分别对客户提供相关产品与服务。

ABB也跨足赛车事业,在2017年冠名赞助国际汽联电动方程式赛车

简史[编辑]

ABB集团成立于1988年,由瑞典通用电气公司(ASEA)和瑞士的布朗-博韦里股份公司(BBC)两家公司合并并更名为ABB。Asea公司成立于1883年,BBC Brown Boveri公司则成立于1891年。

  • 1883年:ASEA成立。
  • 1891年:BBC Brown Boveri成立。
  • 1901年:BBC 建造欧洲第一部蒸气涡轮发动机。
  • 1974年:在香港成立中国业务部,1994年迁往北京。
  • 1987年:在台湾成立艾波比股份有限公司。
  • 1988年:ABB由瑞典的瑞典通用电气公司(Allmänna Svenska Elektriska Aktiebolaget)与瑞士的布朗-博韦里公司合并而成。瑞典通用电气公司仍存在,转变为ABB的控股公司(持股50%)。
  • 1998年:1月18日,ABB在中国第一个生产基地在重庆落成,并且逐渐发展为ABB全球最重要的变压器生产和研发中心之一。
  • 2009年:5月13日,ABB机器人生产基地在中国上海落成,并将机器人全球中心迁至上海。[6]
  • 2009年:11月30日,ABB重组业务部门,新的组织架构包括电力产品、电力系统、离散自动化与运动控制、过程自动化和低压产品五大业务部门。[7]
  • 2018年:12月17日,日立制作所与瑞士ABB达成最终协议,日立以7,040亿日圆(约合64亿美元)收购瑞士ABB集团电力系统部门80.1%的股份,ABB将保留该电力系统事业的19.9%股份。
  • 2020年3月,ABB宣布已同意将其太阳能逆变器业务出售给意大利太阳能逆变器制造商Fimer。 该交易包括ABB在芬兰,意大利和印度的所有制造和研发基地,以及26个国家/地区的800名员工[8]

DHR stock: Danaher Corporation | First 20 minutes reading

 丹纳赫(英语:Danaher Corporation) 是一家位于美国华盛顿哥伦比亚特区的综合企业公司。2018年财富美国500强排名162位。[2

历史[编辑]

1969年创建,前身是一家马萨诸塞州房地产投资信托。主要业务涉及工业制造、电子测量,环境监测、牙科仪器、生命科学和医疗诊断等。[3]


2015年5月13日丹纳赫斥资138亿美元现金收购水和空气过滤系统制造商颇尔公司(Pall Corporation)

2015年5月13日丹纳赫将分拆为两家独立的上市公司,一家是科学和技术增长公司丹纳赫,另一家是专注在专业仪器仪表、自动化、传感和运输技术等方面的多元化工业成长型企业Fortive Corporation(FTV*)


2019年2月25日丹纳赫斥资210亿美元现金以及承担部分养老金债务收购通用电气生命科学公司(GE Life Sciences)的GE生物医药(GE Biopharma)业务

2019年7月1日丹纳赫将旗下的牙科业务Nobel Biocare Systems,KaVo Kerr和Ormco合并成—间独立公司“Envista”,并计划于2019年下半年在纽交所申请IPO上市,股票代码为NVST

2019年10月23日丹纳赫以约7.5亿美元现金出售三项生命科学业务,包括label-free生物分子鉴定、色谱硬件和树脂,以及微载体和颗粒验证标准品业务给赛多利斯(Sartorius)

2020年3月,达纳赫完成以214亿美元收购通用电气生命科学(General Electric Life Sciences)的生物制药业务Cytiva的交易。 该部门制造用于药物研究和制造的设备。[4]

2020年4月,GE医疗生命科学更名为Cytiva(思拓凡)

2020 年 5 月,宣布汤姆·乔伊斯 (Tom Joyce) 将卸任公司 CEO。 他于 2020 年 9 月 1 日被执行副总裁雷尼尔布莱尔取代。[4]

Tuesday, October 19, 2021

辉瑞、强生、默沙东、诺华、罗氏、武田 | 34家大药厂2021年第一季度业绩

 Oct. 19, 2021

Here is the article.

辉瑞、强生、默沙东、诺华、罗氏、武田等34家大药厂2021年第一季度业绩

辉瑞(Pfizer)公布2021年第一季度业绩。营收为145.82亿美元,同比增长45%;净利润为48.77亿美元,同比增长45%。若不包括来自该公司新冠疫苗的营收34.62亿美元,本季度营收增长8%。

艾伯维(AbbVie)公布2021年第一季度业绩。净营收为130.1亿美元,上年同期为86.19亿美元,同比增长51%;归母净利润为35.53亿美元,上年同期为30.1亿美元,同比增长18%。按业务划分,第一季度全球免疫学产品净营收57.44亿美元;全球血液肿瘤学产品净营收16.73亿美元;全球美容产品净营收11.41亿美元;全球神经系统学产品净营收12.48亿美元。

强生(Johnson & Johnson)公布2021年第一季度业绩。季度销售额为223.21亿美元,同比增长7.9%;净利润为61.97亿美元,同比增长6.9%。按业务划分,制药业务销售额121.99亿美元,同比增长9.6%,其中新冠疫苗销售额为1亿美元。医疗器械业务销售额65.79亿美元,同比增长10.9%。消费者健康业务销售额35.43亿美元,同比下降2.3%。

默沙东(Merck & Co)公布2021年第一季度业绩。销售额为120.8亿美元,同比持平;净利润为31.79亿美元,同比下降1%。制药业销售额为106.75亿美元,上年同期为106.55亿美元。动物保健业务销售额为14.18亿美元,同比增长17%。

默沙东(Merck & Co)公布2021年第一季度业绩。销售额为120.8亿美元,同比持平;净利润为31.79亿美元,同比下降1%。制药业销售额为106.75亿美元,上年同期为106.55亿美元。动物保健业务销售额为14.18亿美元,同比增长17%。

礼来(Eli Lilly and Company)公布2021年第一季度业绩,季度营收68.06亿美元,同比增长16%;净利润为13.55亿美元,同比下降7%。

吉利德科学(Gilead Sciences)公布2021年第一季度财报。总营收64.23亿美元,上年同期为55.48亿美元,同比增长16%;净利润17.22亿美元,上年同期为15.38亿美元。分产品来看,Veklury(瑞德西韦)销售额为15亿美元;艾滋病产品销售额为37亿美元,同比下降12%;慢性丙型肝炎病毒(HCV)产品销售额为5.1亿美元,同比下降30%;乙肝病毒和丁型肝炎病毒(HDV)产品销售额为2.2亿美元,同比增长18%;细胞治疗产品销售额为1.91亿美元,同比增长36%。

安进(Amgen)公布2021年第一季度业绩。季度总营收59.01亿美元,上年同期为61.61亿美元。当季净利润16.46亿美元,上年同期为18.25亿美元。

渤健(Biogen Inc.)公布2021年第一季度业绩。季度总营收26.94亿美元,上年同期为35.34亿美元。当季净利润4.1亿美元,上年同期为13.99亿美元。

再生元制药(Regeneron)公布2021年第一季度业绩。季度总营收25.29亿美元,上年同期为18.28亿美元。当季净利润11.15亿美元,上年同期为6.25亿美元。

新冠疫苗研发公司莫德纳(Moderna)公布2021年第一季度业绩。季度营收为19.37亿美元,去年同期为800万美元;净利润为12亿美元,去年同期录得净亏损1.24亿美元。来自新冠疫苗的产品销售额为17.33亿美元,涉及1.02亿剂疫苗。

亚力兄制药(Alexion Pharmaceuticals, Inc.)公布2021年第一季度业绩。季度总营收16.36亿美元,上年同期14.45亿美元。当季净利润6.36亿美元,上年同期为5.58亿美元。

博士康(Bausch Health Cos. Inc.)公布2021年第一季度业绩。季度营收20.27亿美元,上年同期为20.12亿美元。当季净亏损6.1亿美元,上年净亏损1.52亿美元。其中,博士伦营收8.81亿美元,制药业务营收11.46亿美元。

雅培(Abbott)公布2021年第一季度业绩。季度净销售额为104.56亿美元,同比增长35.3%;净利润为17.93亿美元,同比增长217.8%。按业务划分,营养业务销售额为20.36亿美元,同比增长6.9%;诊断业务销售额为40.14亿美元,同比增长119.8%;制药业务销售额为10.70亿美元,同比增长2.5%;医疗器械业务销售额为33.20亿美元,同比增长13.1%。

硕腾(Zoetis)公布2021年第一季度业绩。季度营收18,71亿美元,上年同期15.34亿美元。当季净利润5.59亿美元,上年同期为4.23亿美元。

礼蓝动保(Elanco Animal Health Incorporated)公布2021年第一季度业绩。季度总营收12.42亿美元,上年同期6.58亿美元。当季净亏损6100万美元,上年同期净亏损4900万美元。

诺华制药(Novartis)公布2021年一季度业绩。当季净销售额124.11亿美元,上年同期为122.83亿美元。当季营业利润24.15亿美元,上年同期为27.44亿美元。当季净利润20.59亿美元,上年同期为21.73亿美元。其中,创新药物净销售额101.04亿美元,山德士23.07亿美元。

罗氏(Roche)公布2021年第一季度业绩。当季集团销售额为149亿瑞士法郎,上年同期为151亿瑞士法郎。其中,医药品部门销售额为106亿瑞士法郎(约117亿美元),同比减少14%;诊断部门销售额为43亿瑞士法郎,同比增长50%。

葛兰素史克(GSK)公布2021年第一季度业绩。当季营业额74.18亿英镑(104.46亿美元),比去年同期下降18%。当季总营业利润16.93亿英镑,同比下降16%。营业额按业务划分,处方药业务38.82亿英镑(亿美元),同比下降12%;疫苗业务12.24亿英镑(亿美元),同比下降32%;消费保健品业务23.12亿英镑,同比下降19%。

法国制药巨头赛诺菲(Sanofi)公布2021年第一季度业绩。季度净销售额85.91亿欧元(104.2亿美元),比上年同期下降4.3%。当季净利润15.66亿欧元,比上年同期下降7%。其中,制药业务销售额65.63亿欧元,疫苗业务销售额9.15亿欧元,消费健康业务销售额11.13亿欧元。

阿斯利康(AstraZeneca)公布2021年第一季度业绩,季度营收73.2亿美元,去年同期63.54亿美元;一季度净利润翻番至15.6亿美元,去年同期为7.8亿美元。一季度新冠疫苗营收为2.75亿美元。

拜耳集团(Bayer AG)发布2021财年第一季度业绩。销售额增长2.8%(经汇率与资产组合调整),达到123.28亿欧元。不计特殊项目的息税折旧摊销前利润下降6.2%,为41.18亿欧元。息税前利润增长23.4%,达到30.83亿欧元。净收益增长40.3%,达到20.89亿欧元。作物科学事业部销售额增长6.4%,达到66.46亿欧元。处方药事业部销售额43.65亿欧元(52.9亿美元),与上年同期持平。健康消费品的销售额下降4.4%,达到12.52亿欧元(15.2亿美元)。

诺和诺德(Novo Nordisk)公布2021年第一季度业绩。季度净销售额338.04亿丹麦克朗(约55.14亿美元),上年同期为338.75亿丹麦克朗。季度营业利润149.82亿丹麦克朗,上年同期为163.02亿丹麦克朗。季度净利润126.23亿丹麦克朗,上年同期为118.97亿丹麦克朗。

德国默克集团(Merck KGaA)公布2021年第一季度业绩。净销售额46.31亿欧元,上年同期为43.7亿欧元。全年EBITDA利润14.67亿欧元,上年同期为11.48亿欧元。其中,生命科学业务净销售额21.31亿欧元(约25.85亿美元),保健业务净销售额16.39亿欧元(约19.88亿美元),电子科技业务净销售额8.61亿欧元。

德国疫苗研发厂商拜恩泰科(BioNtech)公布业绩,2021年第一季度总营收20.48亿欧元(约24.84亿美元),上年同期为2770万欧元;净利润11.28亿欧元,上年同期为亏损5340万欧元。

费森尤斯集团(Fresenius SE & Co. KGaA)公布2021年第一季度业绩。当季销售额89.84亿欧元,上年同期为91.35亿欧元。当季营业利润10.06亿欧元,上年同期为11.25亿欧元。当季净利润6.71亿欧元,上年同期为7.3亿欧元。其中,费森尤斯卡比业务销售额17.61亿欧元(约21.36亿美元)。

基立福(Grifols)公布2021年第一季度业绩。季度净销售额11.85亿欧元(约14.37亿美元),比上年同期的12.93亿欧元下降了8.4%。EBITDA利润2.97亿欧元,比上年同期的3.51亿欧元下降了15.5%。集团利润1.3亿欧元,比上年同期的1.86亿欧元下降了30.3%。

Asia

武田(Takeda Pharmaceutical)公布截至2021年3月31日财年业绩。财年营收31978亿日元(约293亿美元),营业利润5093亿日元,净利润3760亿日元。

梯瓦制药(Teva)公布2021年第一季度业绩。季度净营收39.82亿美元,上年同期为43.57亿美元。季度净利润7700万美元,上年同期为6900万美元。

安斯泰来(Astellas Pharma Inc.)公布截至2021年3月31日财年业绩。财年营收12495亿日元(约114亿美元),上财年为13008亿日元。财年营业利润2514亿日元,上财年为2777亿日元。财年净利润2099亿日元,上财年为2232亿日元。

第一三共(Daiichi Sankyo Company, Limited)公布截至2021年3月31日财年业绩。财年营收9625亿日元(约88.1亿美元),上财年为9818亿日元。财年营业利润638亿日元,上财年为1388亿日元。财年净利润759亿日元,上财年为1291亿日元。

大冢控股(Otsuka Holdings Co., Ltd.)公布截至2021年第一季度业绩。季度营收3368亿日元,上年同期为3396亿日元。季度营业利润489亿日元,上年同期为504亿日元。季度净利润447亿日元,上年同期为377亿日元。其中,制药业务营收2253亿日元(约20.6亿美元),营养品业务营收768亿日元,消费品业务营收68.3亿日元。

卫材(Eisai Co., Ltd.)公布截至2021年3月31日财年业绩。财年营收6459亿日元(约59.13亿美元),上财年为6956亿日元。财年营业利润518亿日元,上财年为1255亿日元。财年净利润421亿日元,上财年为1218亿日元。

恒瑞医药发布2021年一季度经营业绩,实现营业收入69.29亿元(约10.76亿美元),同比增长25.37%;实现净利润14.96亿元,同比增长13.77%。

OXY stock: Debt reduction over 1 billion in 2021 | 20 minutes study

Oct. 19, 2021

Here is the article. 

 

Zacks Equity Research

In this article:

Occidental Petroleum OXY announced that it has entered into a definitive agreement to sell its shares in two non-core offshore assets in Ghana. The agreement includes Occidental’s interests in both Jubilee and TEN fields. These fields had combined second-quarter 2021 net production of 22 thousand barrels of oil equivalent per day.

Occidental decided to sell an 18% interest in Jubilees Field and 11% interest in TEN fields to Kosmos Energy KOS for $550 million and the remaining interest in these fields to Ghana National Petroleum Corporation for $200 million. Subject to necessary approval, the agreement is expected to close by fourth-quarter 2021. Proceeds from the asset sale will be utilized to lower the outstanding debt level.

Occidental held Ghana operations for sale on Jun 30, 2021, so when the deal was announced on Oct 14, it did not come as a surprise for investors. Hence, hardly any movement has been noticed in Occidental’s share prices.

Occidental’s Debts and Divestment Goal

Occidental has taken a substantial debt from the market to fund the Anadarko Petroleum acquisition. It outplayed Chevron Corporation CVX in the acquisition battle. This deal expanded Occidental’s presence in the Permian Basin but funding the same increased the company’s debt level. Since the Anadarko acquisition, Occidental has been working relentlessly and selling non-core assets on appropriate occasions.

With the announcement of the divestment of two offshore Ghana assets, the company touched its $10-billion non-core assets divestiture goal. A substantial portion of the net proceeds from assets divestiture has been utilized to lower debt levels. Year to date, the company has lowered the debt level by $4.5 billion from free cash flow and asset sales proceeds.

As of Jun 30, 2021, Occidental had long-term debt (net of current portion) of $35,352 million compared with $36,034 million on Dec 31, 2020. The debt level decrease was due to effective management of debt since the Anadarko acquisition. It is working consistently to strengthen the balance sheet and has been successful in extending near-term $7-billion debt maturity beyond 2025.

Price Performance

In the past 12 months, shares of Occidental have outperformed the industry.